Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial

BACKGROUND: Studies reporting the effects of metabolic surgery, lifestyle intervention, and intensive insulin therapy for the remission of type 2 diabetes (T2DM) has been increasing, with fruitful results better conducted and yielded. However, there are only a few studies on the remission of T2DM us...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue, He, Zhiwei, Yuan, Li, Huang, Wenbin, Li, Doudou, Xiang, Pingping, Chen, Yu, Chen, Guofang, Liu, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563270/
https://www.ncbi.nlm.nih.gov/pubmed/37814256
http://dx.doi.org/10.1186/s12902-023-01461-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563270/
https://www.ncbi.nlm.nih.gov/pubmed/37814256
http://dx.doi.org/10.1186/s12902-023-01461-9

Ejemplares similares